Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Option Award | 2024-12-03 5:50 pm | 2024-12-02 2027-12-02 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 419,286,000 | $0.0012 | 5,908,689,500 (Indirect) | View |
| 2024-11-30 Option Award | 2024-12-03 5:50 pm | 2024-11-30 2034-11-30 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 162,604,000 | $0 | 5,908,689,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 5:48 pm | 2024-12-02 2027-12-02 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 419,286,000 | $0.0012 | 5,335,886,800 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Sandip I Director | 0 | $0 | 1,259,014,000 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Neal James R Director | 0 | $0 | 335,286,000 (Direct) | View |
Ownership | 2024-11-22 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner | 0 | $0 | 8,632,790,000 (Direct) | View |
| 2024-11-14 Option Award | 2024-11-18 8:02 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,404,622,000 | $0 | 4,907,513,500 (Indirect) | View |
| 2024-10-31 Option Award | 2024-11-01 6:00 pm | 2024-10-31 2034-10-31 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 79,684,000 | $0 | 79,684,000 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 6:34 pm | 2024-09-30 2034-09-30 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 175,080,000 | $0 | 175,080,000 (Direct) | View |
| 2024-09-17 Option Award | 2024-09-18 4:40 pm | N/A 2034-09-17 | Akari Therapeutics Plc | AKTX | Bazemore Robert B Director | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 4:30 pm | N/A 2034-06-28 | Akari Therapeutics Plc | AKTX | Grissinger Michael Director | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2024-06-30 Option Award | 2024-07-02 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 91,396,000 | $0 | 3,502,891,500 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 4:30 pm | N/A 2034-06-28 | Akari Therapeutics Plc | AKTX | Hashad Mohamed Wa'el Ahmed Director | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 4:30 pm | N/A 2034-06-28 | Akari Therapeutics Plc | AKTX | WILLIAMS DONALD A Director | 5,000,000 | $0 | 5,000,000 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 4:30 pm | N/A 2034-06-28 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 10,000,000 | $0 | 10,000,000 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:45 pm | 2024-05-31 2027-05-31 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,326,258,000 | $0.0009 | 4,737,753,500 (Indirect) | View |
| 2024-05-31 Option Award | 2024-06-04 4:45 pm | 2024-05-31 2027-05-31 | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 1,326,258,000 | $0.0009 | 5,823,572,800 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:46 pm | N/A N/A | Akari Therapeutics Plc | AKTX | DICICCO WENDY F Interim CFO | 158,473,915 | $0 | 158,473,915 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-30 9:45 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer | 479,569,892 | $0 | 1,018,027,792 (Direct) | View |
Ownership | 2024-01-02 8:06 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Jacques Rachelle Suzanne Chief Executive Officer | 0 | $0 | 928,545,300 (Direct) | View |
Ownership | 2024-01-02 8:00 pm | 2024-07-17 2033-07-17 | Akari Therapeutics Plc | AKTX | DICICCO WENDY F Interim CFO | 0 | $0 | 5,000,000 (Direct) | View |
Ownership | 2024-01-02 7:56 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 0 | $0 | 2,612,011,500 (Indirect) | View |
Ownership | 2024-01-02 7:49 pm | N/A 2033-06-30 | Akari Therapeutics Plc | AKTX | Hashad Mohamed Wa'el Ahmed Director | 0 | $0 | 5,000,000 (Direct) | View |
Ownership | 2024-01-02 6:58 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director | 0 | $0 | 3,494,957,900 (Direct) | View |
Ownership | 2024-01-02 6:41 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Grissinger Michael Director | 0 | $0 | 36,500,000 (Direct) | View |
Ownership | 2024-01-02 6:35 pm | N/A N/A | Akari Therapeutics Plc | AKTX | WILLIAMS DONALD A Director | 0 | $0 | 39,850,000 (Direct) | View |